---
title: 'Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial
  infarction: a network meta-analysis'
date: '2024-01-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38264795/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240124170612&v=2.18.0
source: heidelberg[Affiliation]
description: 'BACKGROUND: Balancing the risk of bleeding and thrombosis after acute
  myocardial infarction (AMI) is challenging, and the optimal antithrombotic therapy
  remains uncertain. The potential of non-vitamin K antagonist oral anticoagulants
  (NOACs) to prevent ischaemic cardiovascular events is promising, but the evidence
  remains ...'
disable_comments: true
---
BACKGROUND: Balancing the risk of bleeding and thrombosis after acute myocardial infarction (AMI) is challenging, and the optimal antithrombotic therapy remains uncertain. The potential of non-vitamin K antagonist oral anticoagulants (NOACs) to prevent ischaemic cardiovascular events is promising, but the evidence remains ...